Viser treff 421-440 av 690

    • Innføring av prosedyre for legemiddelsamstemming ser ikke ut til å redusere uoverensstemmelser i legemiddellistene i Helse Nord HF 

      Al-Sayad, Ali (Master thesis; Mastergradsoppgave, 2016-05-12)
      Bakgrunn: Uoverensstemmelser (UOr) mellom legemiddellister i sykehus og hva pasientene faktisk tar av legemidler forekommer hyppig. Det kan være flere årsaker til dette, blant annet dårlig kommunikasjon mellom omsorgsnivå eller mellom helsepersonell og pasient. Problemet øker med økende antall legemidler. Helse Nord er i ferd med å innføre prosedyre for legemiddelsamstemming (LMS) for å sikre at ...
    • Regulation of ERK3/4 Function via Specific Protein-Protein Interactions 

      Luong, Bao Quoc (Master thesis; Mastergradsoppgave, 2016-05-12)
      The mitogen-activated protein kinase 5 (MK5) binds to extracellular signal-regulated kinase 3 and 4(ERK3 and ERK4) through a unique FRIEDE motif in ERK3/4. 100 amino acids C-terminal in MK5 is sufficient for this binding. MK5s subcellular localization and activity is regulated by the atypical MAP kinase ERK3 and ERK4. In this project we wanted to express and purify full-length and different domains ...
    • Legemiddelgjennomganger hos psykisk utviklingshemmede i Oslo kommune. Legemiddelrelaterte problemer og tiltak 

      Mohammed, Amani Qasem (Master thesis; Mastergradsoppgave, 2016-05-12)
      Bakgrunn: Systematiske legemiddelgjennomganger i tverrfaglig team kan være til hjelp for å identifisere potensielle og aktuelle legemiddelrelaterte problemer (LRP). Oslo kommune valgte i 2015 å prioritere legemiddelgjennomganger for psykisk utviklingshemmede, en gruppe mennesker som bruker mange legemidler. Dette er den første studien på legemiddelgjennomganger og identifisering av LRP blant psykisk ...
    • Eksperimentell in vitro ”screening” og molekylær dokking av forbindelser med mulig hemmende effekt på Thermolysin og Pseudolysin 

      Bilto, Irina Victorovna (Master thesis; Mastergradsoppgave, 2011-06)
      To substrater ble brukt i de eksperimetelle studiene. De er referet til som Bradykinin-lignende substrat og AGLA substrat i oppgaven. De eksperimentelle forsøkene gav Km verdi for Bradykinin lignende substrat for Thermolysin fra Bacillus thermoproteolyticus eubakterie på 17.7 +/- 4.3 μM og Pseudolysin fra Pseudomonas aeruginosa på 7.4 +/- 1.3 μM. For ”AGLA” substrat ble Km for Thermolysin målt til ...
    • Topical liposomes treated by probe-sonication. Study on process and composition using statistical experimental design and multivariate evaluation 

      Chemeda, Ayantu Edossa (Master thesis; Mastergradsoppgave, 2015-10-01)
      Abstract A size distribution between 200 and 300 nm and a high drug entrapment is desirable for liposomes intended for topical application. In an early phase of drug development, small batch sizes are also wanted. Dual Asymmetric Centrifugation (DAC) meets these requirement and was our method of choice. But, after successful production of a few DAC-liposome batches with drug entrapment of ...
    • Reply to letter to the editor 

      Bøhn, Thomas; Cuhra, Marek; Traavik, Terje; Sanden, Monica; Fagan, John; Primicerio, Raul (Journal article; Tidsskriftartikkel; Peer reviewed, 2015-04-01)
    • Are ready for Market Genetically Modified, Conventional and Organic Soybeans Substantially Equivalent as Food and Feed? 

      Bøhn, Thomas; Cuhra, Marek; Traavik, Terje; Fagan, John (Chapter; Bokkapittel, 2015)
      Important compositional elements, including residues of herbicides, were investigated in commercial soy varieties grown within the same geographical area. These included genetically modified, conventional and organic soybeans. Feed made from these soybeans was subsequently fed to the model organism Daphnia magna, while measuring the fitness performance (survival, growth and reproduction) during the ...
    • Cry1Ab Protein from Bacillus thuringiensis and MON810 cry1Ab-transgenic Maize Exerts No Adjuvant Effect After Airway Exposure 

      Andreassen, Monica; Bøhn, Thomas; Wikmark, Odd Gunnar; van den Berg, Johnnie; Løvik, Martinus; Traavik, Terje; Nygaard, Unni Cecilie (Journal article; Tidsskriftartikkel; Peer reviewed, 2015-02-24)
      The genetically modified (GM) maize event MON810 has been inserted with a processed version of the transgene, cry1Ab, derived from the soil bacterium Bacillus thuringiensis (Bt) to express proteins with insecticidal properties. Such proteins may introduce new allergens and also act as adjuvants that promote allergic responses. While focus has been on safe consumption and hence the oral exposure to ...
    • Drug permeability across a phospholipid vesicle based barrier: A novel approach for studying passive diffusion 

      Flaten, Gøril Eide; Dhanikula, Anand Babu; Luthman, Kristina; Brandl, Martin (Journal article; Peer reviewed; Tidsskriftartikkel, 2005-10)
      The aim of this study was to develop a novel predictive medium-throughput screening method for drug permeability, with use of a tight barrier of liposomes on a filter support. To our knowledge no one has succeeded in depositing membrane barriers without the use of inert solvent such as hexadecane. The first part of the study involved development of a protocol for preparation of these barriers, which ...
    • Drug permeability across a phospholipid vesicle based barrier: 3. Characterization of drug-membrane interactions and the effect of agitation on the barrier integrity and on the permeability 

      Flaten, Gøril Eide; Skar, Merete L.; Luthman, Kristina; Brandl, Martin (Journal article; Tidsskriftartikkel; Peer reviewed, 2007)
      Recently, we reported on the development and structural characterization of a phospholipid vesicle based barrier useful for medium throughput screening of passive drug permeability. Here, we investigate the physical and functional integrity of the phospholipid vesicle based barriers to agitation by stirring or shaking, and whether agitation affects drug permeability of sulpiride, metoprolol and ...
    • (Phospho)lipid-based nanosystems for skin administration 

      Vanić, Željka; Holsæter, Ann Mari; Skalko-Basnet, Natasa (Journal article; Tidsskriftartikkel; Peer reviewed, 2015-10)
      Nanotechnology and nanomedicine provide a platform for advanced therapeutic strategies for dermal and transdermal drug delivery. The focus of this review is on the current state-of-art in lipid-based nanotechnology and nanomedicine for (trans)dermal drug therapy. Drug delivery nanosystems based on the (phospho)lipid constituents are characterized and compared, with the emphasis on their ability ...
    • Liposomal formulations of poorly soluble camptothecin: drug retention and biodistribution 

      Flaten, Gøril Eide; Chang, Ting-Tung; Phillips, William T.; Brandl, Martin; Bao, Ande; Goins, Beth (Journal article; Tidsskriftartikkel; Peer reviewed, 2012-12-05)
      Context: Camptothecin (CPT) represents a potent anticancer drug. Its therapeutic use however is impaired by both drug solubility, hydrolysis and protein interactions in vivo. Use of liposomes as drug formulation approach could overcome some of these challenges. <p>Objective: The objective of this study was to perform a mechanistic study of the incorporation and retention of the lipophilic parent ...
    • Drug permeability across a phospholipid vesicle-based barrier: 4. The effect of tensides, co-solvent and pH changes on barrier integrity and on drug permeability 

      Flaten, Gøril Eide; Luthman, Kristina; Vasskog, Terje; Brandl, Martin (Journal article; Tidsskriftartikkel; Peer reviewed, 2008-07-03)
      In this study the integrity of the recently developed phospholipid vesicle-based permeability barrier in the presence of a variety of co-solvents and tensides has been investigated. Also included are studies of the influence of these additives on drug permeation and the effect of pH changes on the permeability of ionogenic drug compounds. Permeability experiments using the hydrophilic model ...
    • Aerobic treatment of selective serotonin reuptake inhibitors in landfill leachate 

      Bergersen, Ove; Østnes Hanssen, Kine; Vasskog, Terje (Journal article; Tidsskriftartikkel; Peer reviewed, 2015-01-28)
      Background: Pharmaceuticals used in human medical care are not completely eliminated in the human body and can enter the municipal sewage sludge system and leachate water from landfill both as the parent compound and as their biologically active metabolites. The selective serotonin reuptake inhibitors (SSRIs) have a large potential for unwanted effects on nontarget organisms in the environment. ...
    • Review of GMO safety assessment studies: glyphosate residues in Roundup Ready crops is an ignored issue 

      Cuhra, Marek (Journal article; Tidsskriftartikkel; Peer reviewed, 2015-09-10)
      <p><i>Background - </i>Genetically modified glyphosate-tolerant cultivar varieties have been a commercial success widely known as Roundup Ready plants. As new glyphosate-tolerant varieties are introduced to satisfy agriculture demand, it is relevant to review the scientific evidence that documents the quality and safety of such biotechnology. Assessments of genetically modified glyphosate-tolerant ...
    • Progress toward rationally designed small-molecule peptide and peptidomimetic CXCR4 antagonists 

      Våbenø, Jon; Haug, Bengt Erik; Rosenkilde, Mette M. (Journal article; Tidsskriftartikkel; Peer reviewed, 2015-06)
      Over the last five years, X-ray structures of CXC chemokine receptor 4 (CXCR4) in complex with three different ligands (the small-molecule antagonist IT1t, the polypeptide antagonist CVX15, and the viral chemokine antagonist vMIP-II) have been released. In addition to the inherent scientific value of these specific X-ray structures, they (i) provide a reliable structural ...
    • The Seralini affair: degeneration of Science to Re-Science? 

      Fagan, John; Traavik, Terje; Bøhn, Thomas (Journal article; Tidsskriftartikkel; Peer reviewed, 2015-08-29)
      A paper reporting findings relevant to safety of the genetically modified (GM) maize NK603 and the herbicide Roundup (Séralini et al., Food Chem Toxicol. 50:4221–4231, 2012) was retracted against the wishes of the authors, and subsequently republished in another peer-reviewed journal (Séralini et al. Environ Sci Europe, doi:10.1186/s12302- 014-0014-5, 2014). These events exemplify a trend in which ...
    • Kan nanopartikulære formuleringer bedre behandlingen av genitale infeksjoner? 

      Jøraholmen, May Wenche; Acharya, Ganesh; Skalko-Basnet, Natasa (Journal article; Tidsskriftartikkel; Peer reviewed, 2015-04-20)
      Bruk av nanoteknologi innenfor medisin er økende, og mange nanopartikulære såkalte «drug delivery-systemer» er allerede ute på markedet og enda flere er i pipeline. Det er blant annet stor interesse for bruk av polymeriske miceller, dendrimerer, liposomer og polymeriske nanopartikler som nanobærere for legemidler. Potensialet som ligger i bruk av nanoteknologi er fremdeles ikke fullt utnyttet ...
    • Probing the molecular interactions between CXC chemokine receptor 4 (CXCR4) and an arginine-based tripeptidomimetic antagonist (KRH-1636) 

      Zachariassen, Zack George; Karlshøj, Stefanie; Haug, Bengt Erik; Rosenkilde, Mette M.; Våbenø, Jon (Journal article; Tidsskriftartikkel; Peer reviewed, 2015-09-23)
      We here report an experimentally verified binding mode for the known tripeptidomimetic CXCR4 antagonist KRH-1636 (1). A limited SAR study based on the three functionalities of 1 was first conducted, followed by site-directed mutagenesis studies. The receptor mapping showed that both the potency and affinity of 1 were dependent on the transmembrane residues His113, Asp171, Asp262, and His281 and also ...
    • Efflux pump-mediated drug resistance in Burkholderia 

      Podnecky, Nicole; Rhodes, Katherine A.; Schweizer, Herbert P. (Journal article; Tidsskriftartikkel; Peer reviewed, 2015-04-14)
      Several members of the genus Burkholderia are prominent pathogens. Infections caused by these bacteria are difficult to treat because of significant antibiotic resistance. Virtually all Burkholderia species are also resistant to polymyxin, prohibiting use of drugs like colistin that are available for treatment of infections caused by most other drug resistant Gram-negative bacteria. Despite clinical ...